Network


Latest external collaboration on country level. Dive into details by clicking on the dots.

Hotspot


Dive into the research topics where Elizabeth K. Norton is active.

Publication


Featured researches published by Elizabeth K. Norton.


Virology | 1992

NYVAC: a highly attenuated strain of vaccinia virus.

James Tartaglia; Marion E. Perkus; Jill Taylor; Elizabeth K. Norton; Jean-Christophe Audonnet; William I. Cox; Stephen W. Davis; Johanna Van Der Hoeven; Bernard Meignier; Michel Riviere; Bernard Languet; Enzo Paoletti

A highly attenuated vaccinia virus strain, NYVAC (vP866), was derived from a plaque-cloned isolate of the Copenhagen vaccine strain by the precise deletion of 18 open reading frames (ORFs) from the viral genome. Among the ORFs deleted from NYVAC (vP866) are two genes involved in nucleotide metabolism, the thymidine kinase (ORF J2R) and the large subunit of the ribonucleotide reductase (ORF I4L); the gene encoding the viral hemagglutinin (ORF A56R); the remnant (ORF A26L) of a highly expressed gene responsible for the formation of A-type inclusion bodies; the disrupted gene (ORFs B13R/B14R) normally encoding a serine protease inhibitor; and a block of 12 ORFs bounded by two known viral host range regulatory functions (ORFs C7L through K1L). Within this block a secretory protein (ORF N1L) implicated in viral virulence and a functional complement 4b binding protein (ORF C3L) are encoded. The ORFs were deleted in a manner which prevents the synthesis of undesirable novel gene products. The attenuation characteristics of the derived NYVAC strain were compared in in vitro and in vivo studies with those of the Western Reserve (WR) laboratory strain, the New York City Board of Health vaccine strain (Wyeth), the parental plaque-cloned isolate (VC-2) of the Copenhagen vaccine strain used to derive NYVAC, and the avipox virus canarypox (ALVAC), which is naturally restricted for replication to avian species. The NYVAC strain was demonstrated to be highly attenuated by the following criteria: (a) no detectable induration or ulceration at the site of inoculation on rabbit skin; (b) rapid clearance of infectious virus from the intradermal site of inoculation on rabbit skin; (c) absence of testicular inflammation in nude mice; (d) greatly reduced virulence as demonstrated by the results of intracranial challenge of both 3-week-old or newborn mice; (e) greatly reduced pathogenicity and failure to disseminate in immunodeficient (nude or cyclophosphamide treated) mice; and (f) dramatically reduced ability to replicate on a variety of human tissue culture cells. Despite these highly attenuated characteristics, the NYVAC strain, as a vector, retains the ability to induce strong immune responses to extrinsic antigens.


Virology | 1990

VACCINIA VIRUS HOST RANGE GENES

Marion E. Perkus; Scott J. Goebel; Stephen W. Davis; Gerard P. Johnson; Keith Limbach; Elizabeth K. Norton; Enzo Paoletti

A gene encoding an 18-kDa polypeptide (ORF C7L) located in the vaccinia virus HindIII C fragment was shown to be functionally equivalent to previously described host range gene (ORF K1L) spanning the HindIII K/M fragment junction. Either C7L or K1L host range gene is necessary and sufficient by itself to allow replication of vaccinia virus on human cells. Deletion of both C7L and K1L genes from the wild-type vaccinia genome is required to derive a virus deficient for replication on human cells. Further, an ORF encoding a 77-kDa polypeptide derived from cowpox (CP77kDa) and previously shown to allow vaccinia to overcome the restriction for replication on Chinese hamster ovary cells could substitute for the vaccinia host range genes C7L and K1L in permitting replication of the virus on human cells. Additionally, the three unique host range genes C7L, K1L, and CP77kDa were functionally equivalent for vaccinia replication on pig kidney cells, but not on rabbit kidney cells.


Virology | 1992

Nonreplicating viral vectors as potential vaccines: recombinant canarypox virus expressing measles virus fusion (F) and hemagglutinin (HA) glycoproteins.

Jill Taylor; Randall Weinberg; James Tartaglia; Christopher D. Richardson; Ghalib Alkhatib; Dalius J. Briedis; Max J. G. Appel; Elizabeth K. Norton; Enzo Paoletti

The development of canarypox virus (CPV) recombinants expressing the hemagglutinin (HA) and fusion (F) glycoproteins of measles virus (MV) is described. Inoculation of the CPV-MV recombinants into avian or nonavian tissue culture substrates led to the expression of authentic MVF and MVHA as determined by radioimmunoprecipitation and surface immunofluorescence. In contrast to avian-derived tissue culture, no productive replication of the CPV recombinant was evident in tissue culture cells derived from nonavian origin. On inoculation of dogs, a species restricted for avipoxvirus replication, the recombinants elicited a protective immune response against a lethal canine distemper virus (CDV) challenge. The level of MV neutralizing antibodies and the level of protection induced against CDV challenge achieved by the host-restricted CPV vector were equivalent to that obtained by vaccinia virus vectors expressing the same MV antigens.


Virology | 1991

Deletion of 55 open reading frames from the termini of vaccinia virus

Marion E. Perkus; Scott J. Goebel; Stephen W. Davis; Gerard P. Johnson; Elizabeth K. Norton; Enzo Paoletti

Each copy of the inverted terminal repeat of vaccinia virus consists of 8 kb of DNA containing 9 ORFS flanked near the terminus of the genome by 4 kb of repetitive DNA which in turn contains blocks of tandem repeats. Using plasmids containing repetitive DNA as the external arm, we have generated deletions at both the left and the right termini of the vaccinia genome. We report here the engineered deletion within a single vaccinia virus of 32.7 kb of DNA (including 38 ORFS) from the left terminus and 14.9 kb of DNA (including 17 ORFS) from the right terminus.


Virology | 1990

A DNA ligase gene in the copenhagen strain of vaccinia virus is nonessential for viral replication and recombination

Robert J. Colinas; Scott J. Goebel; Stephen W. Davis; Gerard P. Johnson; Elizabeth K. Norton; Enzo Paoletti

Biochemical and genetic analyses have been conducted to determine whether a vaccinia virus open reading frame (orf) with extensive homology to the Saccharomyces cerevisiae DNA ligase gene encodes a functional ligase activity. This orf in HindIII A, designated A50R, is capable of encoding a 552-amino-acid, 63.4-kDa polypeptide. Full-length A50R mRNA produced in vitro directed the synthesis of a polypeptide with an apparent molecular weight of 57 kDa. Significantly, translation reactions programmed with A50R mRNA were capable of ligating a 3-kb Notl restriction fragment into multimers. DNA ligase activity was not detectable when either truncated sense or full-length antisense mRNA was translated in vitro. In extracts prepared from cells infected with wt vaccinia virus, DNA ligase activity was detected as assayed by the formation of a 57 kDa ligase-AMP adduct which was expressed early in the viral replication cycle. In cells infected with a DNA ligase deletion mutant no equivalent AMP-labeled adduct was detected. Relative to wt virus, the DNA ligase deletion mutant exhibited no significant differences in homologous recombination. These results indicate that the vaccinia orf A50R encodes a functional DNA ligase expressed early in infection, but this DNA ligase is nonessential for either recombination or viral replication.


Archive | 1993

NYVAC vaccinia virus recombinants comprising heterologous inserts

Enzo Paoletti; Marion E. Perkus; Jill Taylor; James Tartaglia; Elizabeth K. Norton; Michel Riviere; Charles de Taisne; Keith J. Limbach; Gerard P. Johnson; Steven E. Pincus; William I. Cox; Jean-Christophe Audonnet; Russell Robert Gettig


Archive | 1995

Alvac canarypox virus recombinants comprising heterlogous inserts

Enzo Paoletti; Marion E. Perkus; Jill Taylor; James Tartaglia; Elizabeth K. Norton; Michel Riviere; Charles de Taisne; Keith J. Limbach; Gerard P. Johnson; Steven E. Pincus; William I. Cox; Jean-Christophe Audonnet; Russell Robert Gettig


Archive | 1996

Modified recombinant vaccinia virus and expression vectors thereof

Enzo Paoletti; Marion E. Perkus; Jill Taylor; James Tartaglia; Elizabeth K. Norton; Michel Riviere; Charles de Taisne; Keith J. Limbach; Gerard P. Johnson; Steven E. Pincus; William I. Cox; Jean-Christophe Audonnet; Russell Robert Gettig


Archive | 1995

Trova fowl pox virus recombinants comprising heterologous inserts

Enzo Paoletti; Marion E. Perkus; Jill Taylor; James Tartaglia; Elizabeth K. Norton; Michel Riviere; Charles de Taisne; Keith J. Limbach; Gerard P. Johnson; Steven E. Pincus; William I. Cox; Jean-Christophe Audonnet; Russell Robert Gettig


Archive | 1992

Souche de vaccin mise au point par genie genetique

Enzo Paoletti; Marion E. Perkus; Jill Taylor; James Tartaglia; Elizabeth K. Norton; Michel Riviere; Taisne Charles De; Keith J. Limbach; Gerard P. Johnson; Steven E. Pincus; William I. Cox; Jean-Christophe Francis; Russell Robert Gettig

Collaboration


Dive into the Elizabeth K. Norton's collaboration.

Top Co-Authors

Avatar

Gerard P. Johnson

Rensselaer Polytechnic Institute

View shared research outputs
Top Co-Authors

Avatar

Marion E. Perkus

New York State Department of Health

View shared research outputs
Top Co-Authors

Avatar

Jill Taylor

Rensselaer Polytechnic Institute

View shared research outputs
Top Co-Authors

Avatar
Top Co-Authors

Avatar

Jean-Christophe Audonnet

Rensselaer Polytechnic Institute

View shared research outputs
Top Co-Authors

Avatar

Russell Robert Gettig

Rensselaer Polytechnic Institute

View shared research outputs
Top Co-Authors

Avatar

Steven E. Pincus

State University of New York System

View shared research outputs
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Researchain Logo
Decentralizing Knowledge